{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:49:59Z","timestamp":1776952199942,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the NIH, National Institute of Neurological Disorders and Stroke"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jns.2011.04.011","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T04:40:04Z","timestamp":1304916004000},"page":"118-122","source":"Crossref","is-referenced-by-count":67,"title":["Autonomic dysfunction in PD: A window to early detection?"],"prefix":"10.1016","volume":"310","author":[{"given":"David S.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaToya","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehonatan","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2011.04.011_bb0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm"},{"issue":"10","key":"10.1016\/j.jns.2011.04.011_bb0010","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM199703063361004","article-title":"Sympathetic cardioneuropathy in dysautonomias","volume":"336","author":"Goldstein","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jns.2011.04.011_bb0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10286-007-0396-1","article-title":"Cardiac sympathetic denervation preceding motor signs in Parkinson disease","volume":"17","author":"Goldstein","year":"2007","journal-title":"Clin Auton Res"},{"issue":"8","key":"10.1016\/j.jns.2011.04.011_bb0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.21989","article-title":"Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease","volume":"23","author":"Fujishiro","year":"2008","journal-title":"Mov Disord"},{"issue":"Pt 3","key":"10.1016\/j.jns.2011.04.011_bb0025","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.04.011_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin Auton Res"},{"issue":"12","key":"10.1016\/j.jns.2011.04.011_bb0035","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/mds.22226","article-title":"Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension","volume":"23","author":"Sharabi","year":"2008","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jns.2011.04.011_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2004-817719","article-title":"Autonomic failure in neurodegenerative disorders","volume":"23","author":"Kaufmann","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jns.2011.04.011_bb0045","series-title":"Adrenaline and the inner world: an introduction to scientific integrative medicine","author":"Goldstein","year":"2006"},{"issue":"6","key":"10.1016\/j.jns.2011.04.011_bb0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/01.WNL.0000052690.91036.FF","article-title":"Neurotransmitter specificity of sympathetic denervation in Parkinson's disease","volume":"60","author":"Sharabi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.04.011_bb0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","article-title":"Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy","volume":"73","author":"Orimo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2011.04.011_bb0060","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.parkreldis.2006.05.030","article-title":"Cardiac sympathetic denervation in Lewy body disease","volume":"12","author":"Orimo","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2011.04.011_bb0065","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/mds.21083","article-title":"Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy","volume":"21","author":"Lee","year":"2006","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.jns.2011.04.011_bb0070","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.jns.2011.04.011_bb0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","article-title":"Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease","volume":"16","author":"Kashihara","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.jns.2011.04.011_bb0080","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.wnl.0000249313.25627.2e","article-title":"Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder","volume":"67","author":"Miyamoto","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2011.04.011_bb0085","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000219640.59984.a7","article-title":"Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD","volume":"66","author":"Yoshita","year":"2006","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jns.2011.04.011_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","article-title":"Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease","volume":"240","author":"Suzuki","year":"2006","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.jns.2011.04.011_bb0095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson's disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"issue":"Pt 9","key":"10.1016\/j.jns.2011.04.011_bb0100","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/brain\/awm174","article-title":"Characteristics of orthostatic hypotension in Parkinson's disease","volume":"130","author":"Oka","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.04.011_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2008.04.031","article-title":"Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease","volume":"15","author":"Haensch","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2011.04.011_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.0b013e3181ca014c","article-title":"Association of anosmia with autonomic failure in Parkinson disease","volume":"74","author":"Goldstein","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.04.011_bb0115","series-title":"The role of catechol quinone species in cellular toxicity","author":"Creveling","year":"2000"},{"issue":"3","key":"10.1016\/j.jns.2011.04.011_bb0120","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.jns.2011.04.011_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.abb.2008.03.011","article-title":"Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols","volume":"476","author":"Vauzour","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.jns.2011.04.011_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","article-title":"3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis","volume":"989","author":"Burke","year":"2003","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.jns.2011.04.011_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/tx800405v","article-title":"Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate","volume":"22","author":"Jinsmaa","year":"2009","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.1016\/j.jns.2011.04.011_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-007-0303-9","article-title":"Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine","volume":"115","author":"Burke","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.jns.2011.04.011_bb0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/syn.20696","article-title":"PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S, S)-[(11)C]O-methylreboxetine and HRRT","volume":"64","author":"Ding","year":"2010","journal-title":"Synapse"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11001924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11001924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T23:21:04Z","timestamp":1543792864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X11001924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0022510X11001924"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.04.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}